Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering

ODYSSEY OUTCOMES trial

  • Szarek, Michael
  • Bittner, Vera A
  • Aylward, Philip
  • Baccara-Dinet, Marie
  • Bhatt, Deepak L
  • Diaz, Rafael
  • Fras, Zlatko
  • Goodman, Shaun G
  • Halvorsen, Sigrun
  • Harrington, Robert A
  • Jukema, J Wouter
  • Moriarty, Patrick M
  • Pordy, Robert
  • Ray, Kausik K
  • Sinnaeve, Peter
  • Tsimikas, Sotirios
  • Vogel, Robert
  • White, Harvey D
  • Zahger, Doron
  • Zeiher, Andreas M
  • Steg, Ph Gabriel
  • Schwartz, Gregory G
European Heart Journal 41(44):p 4245-4255, November 21, 2020. | DOI: 10.1093/eurheartj/ehaa649
Copyright © Copyright Oxford University Press 2020.